Global Split-Thickness Skin Grafts for Burns and Extensive Skin Loss Market, By Type (Equipments and Grafts), End User (Hospitals, Ambulatory Surgical Centers, Dermatology Clinics, and Others) - Industry Trends and Forecast to 2031.
Split-Thickness Skin Grafts for Burns and Extensive Skin Loss Market Analysis and Insights
Global split-thickness skin grafts for burns and extensive skin loss market is driven by the increasing incidence of burn injuries, rising awareness about advanced wound care treatments, technological advancements in skin grafting procedures, and a growing number of surgical procedures requiring grafting. Also, the market benefits from significant investments in healthcare infrastructure and research, a surge in the number of specialized burn care centers, and the rising demand for minimally invasive procedures. Key players in this market include medical device manufacturers, biotechnology firms, and healthcare providers, all contributing to the development, production, and distribution of innovative grafting materials and techniques. The market is influenced by regulatory approvals, reimbursement policies, and an expanding aging population prone to skin injuries and chronic wounds, creating a robust demand for effective skin graft solutions globally.
Data Bridge Market Research analyzes that the global split-thickness skin grafts for burns and extensive skin loss market is expected to reach USD 588,751.85 thousand by 2031 from USD 283,883.57 thousand in 2023, growing at a CAGR of 10.0% in the forecast period of 2024 to 2031.
Report Metric
|
Details
|
Forecast Period
|
2024 to 2031
|
Base Year
|
2023
|
Historic Years
|
2022 (Customizable to 2016–2021)
|
Quantitative Units
|
Revenue in USD Thousand
|
Segments Covered
|
Type (Equipments and Grafts), End User (Hospitals, Ambulatory Surgical Centers, Dermatology Clinics and Others)
|
Countries Covered
|
U.S., Canada, Mexico, Germany, U.K., France, Italy, Netherlands, Spain, Russia, Switzerland, Turkey, Belgium, Poland, Austria, Portugal, Greece, Slovenia, Czech Republic, Iceland, Sweden, Denmark, Norway, Finland, Rest of Europe, China, Japan, India, South Korea, Rest of Asia-Pacific, Brazil, Rest of South America, South Africa and Rest of Middle East and Africa
|
Market Players Covered
|
Integra LifeSciences, Zimmer Biomet, Organogenesis Inc., AVITA Medical, Exsurco Medical, Inc. (A subsidiary of Bettcher Industries, Inc.), NOUVAG AG, MIMEDX Group, Inc., AlloSource, B.Braun SE, and Smith+Nephew among others
|
Market Definition
The split-thickness skin grafts, used primarily for burns and extensive skin loss, is a specialized sector within the broader medical and surgical field focused on advanced wound care and reconstructive procedures. Split thickness skin grafts involve the transplantation of the epidermis and part of the dermis from a donor site to the affected area, offering a viable solution for patients with severe burns or extensive skin injuries.
Global Split-Thickness Skin Grafts for Burns and Extensive Skin Loss Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Increasing Incidence of Burns and Skin Injuries
The increasing incidence of burns and skin injuries worldwide serves as a significant driver for the global market of split-thickness skin grafts, particularly in treating burns and extensive skin loss. Industrial accidents, domestic mishaps, and natural disasters contribute significantly to the rising number of burn cases annually. In addition, the prevalence of burn injuries is compounded by factors such as urbanization, which increases exposure to fire hazards and industrial risks in densely populated areas. The need to address these complicated medical issues globally is driving the market for split-thickness skin grafts, as patients and healthcare providers alike look for effective treatments for burns and significant skin loss.
- Increasing Advancements in Skin Grafting Techniques
Advancements in skin grafting techniques have significantly propelled the global market for split-thickness skin grafts, particularly in addressing burns and extensive skin loss. Improvements in wound care, anesthetic, and surgical techniques throughout time have improved skin graft technique procedure success rates and results. By expanding the harvested skin to cover a greater area, a technique called meshing has increased grafting efficiency and decreased donor site morbidity. As technology continues to evolve, healthcare providers are better equipped to address complex wound care needs, driving continued market growth through enhanced efficacy and patient satisfaction. Future developments in regenerative medicine and surgical techniques promise further advancements, ensuring a robust trajectory for the market of split-thickness skin grafts globally.
Opportunity
- Growing Awareness and Adoption of the Benefits of Split-Thickness Skin Grafts
Growing awareness and adoption of the benefits of Split-Thickness Skin Grafts (STSG) significantly enhance the global market for burns and extensive skin loss by increasing both patient and healthcare provider demand for these treatments. As more healthcare professionals become educated on the advantages of STSG, such as improved wound healing, reduced infection risks, and better aesthetic outcomes, they are more likely to recommend and utilize these grafts in their practice. As a result, the combination of increased awareness, professional education, and patient demand creates a robust environment for market expansion and innovation in split-thickness skin grafts.
Restraints/Challenges
- Limited Availability of Donor Sites
The limited availability of donor sites presents a significant challenge in the global market for split-thickness skin grafts for burns and extensive skin loss. Donor sites, typically healthy skin from the patient's own body, are crucial for grafting procedures. When donor sites are scarce or insufficient due to the extent of injuries or previous grafting procedures, healthcare providers face difficulties in obtaining adequate graft material. This limitation can result in longer wait times for patients, increased surgical complexity, and potential compromises in graft quality and healing outcomes.
- High Cost of Treatment with Skin Graft Procedures
The high cost associated with split-thickness skin graft procedures serves as a significant restraint in the global market for treating burns and extensive skin loss. These procedures involve multiple expenses, including surgical fees, hospitalization costs, and post-operative care, which can be financially burdensome for patients and healthcare systems alike. In regions with limited healthcare budgets or where insurance coverage is inadequate, the affordability of such treatments becomes a critical concern, potentially limiting access to essential care for patients in need.
Recent Developments
- In June 2024, AVITA Medical, Inc. announced that the Joseph M. Still Burn Center at Doctors Hospital of Augusta is the first U.S. burn center to treat a patient with its newly FDA approved RECELL GO System, a next- generation autologous cell harvesting device that uses a patient’s own skin to treat thermal burn wounds and full thickness skin defects. This milestone will help the company by demonstrating the system's effectiveness and expanding its market presence
- In July 2022, Smith+Nephew has launched the WOUND COMPASS Clinical Support App, a digital tool aiding healthcare professionals in wound assessment and decision-making to standardize care and enhance patient outcomes. This initiative strengthens Smith+Nephew's commitment to improving clinical practice and customer satisfaction through innovative digital solutions
- In October 2022, AlloSource has been awarded a multi-year contract by BARDA, a division of ASPR in HHS, to establish significant inventories of donated skin for treating burn patients following mass casualty events. This contract enhances AlloSource's capabilities to respond effectively to emergency burn care needs and strengthens its partnership with federal healthcare agencies
- In January 2023, Zimmer Biomet's acquisition of Embody, Inc., a company specializing in collagen-based biointegrative solutions for orthopedic soft tissue healing, marks a strategic expansion into advanced wound care and regenerative medicine. This acquisition not only broadens Zimmer Biomet's product portfolio but also enhances its capability to offer advanced treatments that improve patient outcomes and surgeon satisfaction
- In March 2024, Integra Life Sciences recently launched MicroMatrix Flex, a new product designed to facilitate access to challenging anatomical areas in complex surgical cases. This innovative matrix is engineered with flexibility in mind, allowing surgeons easier application and conformability to hard-to-reach or irregular surfaces during procedures
Global Split-Thickness Skin Grafts for Burns and Extensive Skin Loss Market Scope
The global split-thickness skin grafts for burns and extensive skin loss market is segmented into two notable segments based on type and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Type
- Equipments
- Grafts
On the basis of type, the global split-thickness skin grafts for burns and extensive skin loss market is segmented into equipments and grafts.
End User
- Hospitals
- Ambulatory surgical centers
- Dermatology clinics
- Others
On the basis of end user, the global split-thickness skin grafts for burns and extensive skin loss market is segmented into hospitals, ambulatory surgical centers, dermatology clinics, and others.
Global Split-Thickness Skin Grafts for Burns and Extensive Skin Loss Market Regional Analysis/Insights
The global split-thickness skin grafts for burns and extensive skin loss market is segmented into two notable segments based on type and end user.
The countries covered in this market report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Netherlands, Spain, Russia, Switzerland, Turkey, Belgium, Poland, Austria, Portugal, Greece, Slovenia, Czech Republic, Iceland, Sweden, Denmark, Norway, Finland, rest of Europe, China, Japan, India, South Korea, rest of Asia-Pacific, Brazil, rest of South America, South Africa and rest of Middle East and Africa.
North America is expected to dominate the global split-thickness skin grafts for burns and extensive skin loss market due to its advanced healthcare infrastructure, high incidence of burn injuries, significant healthcare expenditure, and favorable reimbursement policies. The U.S. is expected to dominate in the North America region due to strong focus on research and development in medical technologies supports this market leadership. China is expected to dominate the Asia-Pacific region due to its rapidly expanding healthcare infrastructure, increasing incidence of burn injuries, and growing investments in medical research and development. Germany is expected to dominate in the Europe region due to its advanced technology adoption, robust healthcare infrastructure, and mature market.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Split-Thickness Skin Grafts for Burns and Extensive Skin Loss Market Share Analysis
The global split-thickness skin grafts for burns and extensive skin loss market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the market.
Some of the major market players operating in the market are Integra LifeSciences, Zimmer Biomet, Organogenesis Inc., AVITA Medical, Exsurco Medical, Inc. (A subsidiary of Bettcher Industries, Inc.), NOUVAG AG, MIMEDX Group, Inc., AlloSource, B. Braun SE, and Smith+Nephew among others.
SKU-